Taiwan Biomaterial Co., Ltd. (TPEX:6649)

Taiwan · Delayed Price · Currency is TWD

45.10

-0.10 (-0.22%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Medical Products			72.84M	127.31M	41.67M	18.08M	16.54M
Medical Products Growth			-42.79%	205.48%	130.56%	9.26%	1547.71%
Total			72.84M	127.31M	41.67M	18.08M	16.54M
Total Growth			-42.79%	205.48%	130.56%	9.26%	1547.71%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States			70.45M	124.76M	38.34M	13.68M	13.88M
United States Growth			-43.54%	225.42%	180.21%	-1.45%	-
Taiwan			2.39M	2.55M	3.34M	4.39M	2.66M
Taiwan Growth			-5.97%	-23.71%	-24.06%	65.21%	164.84%
Total			72.84M	127.31M	41.67M	18.08M	16.54M
Total Growth			-42.79%	205.48%	130.56%	9.26%	1547.71%

Source: S&P Global Market Intelligence.